Professor Gillian Leng appointed NICE Chief Executive
Professor Gillian Leng has been appointed as the new Chief Executive of NICE and will take over from Sir Andrew Dillon in early April.
List view / Grid view
Professor Gillian Leng has been appointed as the new Chief Executive of NICE and will take over from Sir Andrew Dillon in early April.
New research has revealed that despite a rising number of women in STEM publishing papers, there is a large gender difference due to females leaving academia.
The next Chief Executive of the National Institute for Health Research’s Clinical Research Network has been announced as Dr William van’t Hoff.
Professor Trevor Jones, CBE, FMedSci is the new chairman of EMCA, a body that seeks to advocate for evidence-based policy and improving supply and manufacture of quality medicinal cannabis.
Dr Stephen Hahn has been voted into the role of FDA commissioner by the US Senate, taking over the role from Ned Sharpless.
The ABPI’s board has unanimously appointed Dr Richard Torbett as Chief Executive, commencing 1 January 2020.
President Trump has announced his intent to nominate Stephen Hahn as Commissioner of Food and Drugs at the Department of Health and Human Services.
Haseeb Ahmad from Novartis Pharmaceuticals has been confirmed as the new president of the The Association of the British Pharmaceutical Industry (ABPI).
The Champalimaud Vision Award has been awarded to research teams for the development of a gene therapy...
European Pharmaceutical Review welcomes the newest member of its Editorial Advisory Board
Oramed announced today the appointment of Dr Simon Bruce MD to the newly created position of Vice President of Medical Affairs...
Dr Steven Baertschi has joined the editorial advisory board of European Pharmaceutical Review.
Ashfield welcomes Greg Flynn to the US and Mick O’Leary to Japan…
11 November 2015 | By Victoria White
The US National Academy of Medicine (NAM) recently announced the election of Dr Vasant “Vas” Narasimhan as a member of the Academy.
Bristol-Myers Squibb Company (NYSE:BMY) today announced that Giovanni Caforio, M.D., has been appointed chief operating officer and elected to Bristol-Myers Squibb’s Board of Directors, effective June 5, 2014. He will continue to report to Lamberto Andreotti, chief executive officer. In addition to his current responsibilities as chief commercial officer, Caforio…